Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

Similar articles for PubMed (Select 20980515)

1.

Reverse genetics generation of chimeric infectious Junin/Lassa virus is dependent on interaction of homologous glycoprotein stable signal peptide and G2 cytoplasmic domains.

Albariño CG, Bird BH, Chakrabarti AK, Dodd KA, White DM, Bergeron E, Shrivastava-Ranjan P, Nichol ST.

J Virol. 2011 Jan;85(1):112-22. doi: 10.1128/JVI.01837-10. Epub 2010 Oct 27.

2.

Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines.

Cheng BY, Ortiz-Riaño E, de la Torre JC, Martínez-Sobrido L.

J Virol. 2015 Jul 15;89(14):7373-84. doi: 10.1128/JVI.00307-15. Epub 2015 May 13.

PMID:
25972555
3.

Highly Pathogenic New World and Old World Human Arenaviruses Induce Distinct Interferon Responses in Human Cells.

Huang C, Kolokoltsova OA, Yun NE, Seregin AV, Ronca S, Koma T, Paessler S.

J Virol. 2015 Jul 15;89(14):7079-88. doi: 10.1128/JVI.00526-15. Epub 2015 Apr 29.

PMID:
25926656
4.

Human Plasmacytoid Dendritic Cells Elicited Different Responses after Infection with Pathogenic and Nonpathogenic Junin Virus Strains.

Negrotto S, Mena HA, Ure AE, Jaquenod De Giusti C, Bollati-Fogolín M, Vermeulen EM, Schattner M, Gómez RM.

J Virol. 2015 Jul 15;89(14):7409-13. doi: 10.1128/JVI.01014-15. Epub 2015 Apr 29.

PMID:
25926646
5.

A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses.

Safronetz D, Mire C, Rosenke K, Feldmann F, Haddock E, Geisbert T, Feldmann H.

PLoS Negl Trop Dis. 2015 Apr 17;9(4):e0003736. doi: 10.1371/journal.pntd.0003736. eCollection 2015 Apr.

6.

Lassa-vesicular stomatitis chimeric virus safely destroys brain tumors.

Wollmann G, Drokhlyansky E, Davis JN, Cepko C, van den Pol AN.

J Virol. 2015 Jul 1;89(13):6711-24. doi: 10.1128/JVI.00709-15. Epub 2015 Apr 15.

PMID:
25878115
7.

Sequence variability and geographic distribution of Lassa virus, Sierra Leone.

Leski TA, Stockelman MG, Moses LM, Park M, Stenger DA, Ansumana R, Bausch DG, Lin B.

Emerg Infect Dis. 2015 Apr;21(4):609-18. doi: 10.3201/eid2104.141469.

8.

The glycoprotein precursor gene of junin virus determines the virulence of the romero strain and the attenuation of the candid #1 strain in a representative animal model of argentine hemorrhagic Fever.

Seregin AV, Yun NE, Miller M, Aronson J, Smith JK, Walker AG, Smith JN, Huang C, Manning JT, de la Torre JC, Paessler S.

J Virol. 2015 Jun 1;89(11):5949-56. doi: 10.1128/JVI.00104-15. Epub 2015 Mar 25.

PMID:
25810546
9.

Cis- and cell type-dependent trans-requirements for Lassa virus-like particle production.

Urata S, Yasuda J.

J Gen Virol. 2015 Feb 25. pii: vir.0.000105. doi: 10.1099/vir.0.000105. [Epub ahead of print]

PMID:
25722347
10.

Development of live-attenuated arenavirus vaccines based on codon deoptimization.

Cheng BY, Ortiz-Riaño E, Nogales A, de la Torre JC, Martínez-Sobrido L.

J Virol. 2015 Apr;89(7):3523-33. doi: 10.1128/JVI.03401-14. Epub 2015 Jan 14.

PMID:
25589652
11.

Potent inhibition of Junín virus infection by interferon in murine cells.

Huang C, Walker AG, Grant AM, Kolokoltsova OA, Yun NE, Seregin AV, Paessler S.

PLoS Negl Trop Dis. 2014 Jun 5;8(6):e2933. doi: 10.1371/journal.pntd.0002933. eCollection 2014 Jun.

12.

Evolution of recombinant lymphocytic choriomeningitis virus/Lassa virus in vivo highlights the importance of the GPC cytosolic tail in viral fitness.

Sommerstein R, Ramos da Palma J, Olschläger S, Bergthaler A, Barba L, Lee BP, Pasquato A, Flatz L.

J Virol. 2014 Aug;88(15):8340-8. doi: 10.1128/JVI.00236-14. Epub 2014 May 14.

13.

High-resolution structure of the N-terminal endonuclease domain of the Lassa virus L polymerase in complex with magnesium ions.

Wallat GD, Huang Q, Wang W, Dong H, Ly H, Liang Y, Dong C.

PLoS One. 2014 Feb 7;9(2):e87577. doi: 10.1371/journal.pone.0087577. eCollection 2014.

14.

Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidate.

Zapata JC, Goicochea M, Nadai Y, Eyzaguirre LM, Carr JK, Tallon LJ, Sadzewicz L, Myers G, Fraser CM, Su Q, Djavani M, Lukashevich IS, Salvato MS.

J Virol. 2014 Mar;88(6):3058-66. doi: 10.1128/JVI.03035-13. Epub 2013 Dec 11.

15.

Utilization of human DC-SIGN and L-SIGN for entry and infection of host cells by the New World arenavirus, Junín virus.

Martinez MG, Bialecki MA, Belouzard S, Cordo SM, Candurra NA, Whittaker GR.

Biochem Biophys Res Commun. 2013 Nov 22;441(3):612-7. doi: 10.1016/j.bbrc.2013.10.106. Epub 2013 Oct 29.

16.

[Arenavirus infections].

Tani H, Fukushi S, Yoshikawa T, Saijo M, Morikawa S.

Uirusu. 2012;62(2):229-38. Review. Japanese.

17.

Transcriptome analysis of human peripheral blood mononuclear cells exposed to Lassa virus and to the attenuated Mopeia/Lassa reassortant 29 (ML29), a vaccine candidate.

Zapata JC, Carrion R Jr, Patterson JL, Crasta O, Zhang Y, Mani S, Jett M, Poonia B, Djavani M, White DM, Lukashevich IS, Salvato MS.

PLoS Negl Trop Dis. 2013 Sep 12;7(9):e2406. doi: 10.1371/journal.pntd.0002406. eCollection 2013.

18.

Comparative analysis of disease pathogenesis and molecular mechanisms of New World and Old World arenavirus infections.

McLay L, Liang Y, Ly H.

J Gen Virol. 2014 Jan;95(Pt 1):1-15. doi: 10.1099/vir.0.057000-0. Epub 2013 Sep 25. Review.

19.

Generation of recombinant arenavirus for vaccine development in FDA-approved Vero cells.

Cheng BY, Ortiz-Riaño E, de la Torre JC, Martínez-Sobrido L.

J Vis Exp. 2013 Aug 1;(78). doi: 10.3791/50662.

20.

Mice lacking functional STAT1 are highly susceptible to lethal infection with Lassa virus.

Yun NE, Seregin AV, Walker DH, Popov VL, Walker AG, Smith JN, Miller M, de la Torre JC, Smith JK, Borisevich V, Fair JN, Wauquier N, Grant DS, Bockarie B, Bente D, Paessler S.

J Virol. 2013 Oct;87(19):10908-11. doi: 10.1128/JVI.01433-13. Epub 2013 Jul 31.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk